← Eichor
Study identifier: NCT06161285 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Association of Dysbiosis and Immune Response in Bronchiolitis in Under 12 Months -Old Infants

Condition: Bronchiolitis  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhaseN/A
Planned participants120
Who can joinAll sexes, 1 Day to 12 Months
Healthy volunteersNo

About this study

Acute bronchiolitis is a common disease in children under the age of two, caused mainly by the respiratory syncytial virus (RSV). Furthermore, given the same medical history, it is still very difficult to predict the course and severity of the infection at the onset of symptoms, Some studies have highlighted the importance of the microbiota (intestinal, oral or nasopharyngeal) and of the immune response to RSV in children, We will include 80 children under 2 years old with hospitalized bronchiolitis and non-hospitalized bronchiolitis. Oral, nasal and stool samples will be taken to study the various microbiota in search of dysbiosis. A capillary blood sample will be taken for immune studies.

This description comes directly from the study's public registry record.

Talk to the study team

Etienne BIZOT, Doctor  ·  33145374618  ·  etienne.bizot@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (3)

APHP, Antoine Béclère HospitalClamart, FranceRecruiting
AP-HP,Raymond Poincaré HospitalGarches, FranceRecruiting
Réanimation médico-chirurgicale NeckerParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06161285